Wilmington, MA – Charles River Laboratories has announced the appointment of Glenn Coleman as Chief Financial Officer. About Charles River Laboratories: Charles River Laboratories International, Inc. (NYSE: CRL) is a global company that provides essential products and services to accelerate research and drug development for pharmaceutical and biotechnology companies, government agencies, and leading academic institutions worldwide. The company’s dedicated employees focus on delivering precisely what clients need to improve and expedite the discovery, early-stage development, and safe manufacture of new therapies. Charles River aims to transform to meet the current and future needs of its clients and the evolving industry landscape. The company is actively strengthening its leadership team to drive long-term growth, greater efficiency, and operational excellence, as evidenced by recent executive appointments. With a mission to advance scientific innovation and create healthier lives, Charles River is positioned as a leader in the life sciences industry.

For more information on Charles River Laboratories please visit: https://www.criver.com/

Charles River Laboratories
251 Ballardvale St
Wilmington, MA 1887
Phone: 781-222-6000
LinkedIn Page: https://www.linkedin.com/company/charles-river-laboratories/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved